Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series.

BACKGROUND AND DESIGN A variety of therapeutic regimens has been used in keloids and hypertrophic scars with unsatisfactory final results. Application of cryosurgery could be beneficial since it was reported to produce less scarring after treatment of skin tumors compared with other surgical procedures. We performed a prospective consecutive trial of randomly enrolled case series including 32 months of average follow-up to assess the outcomes of cryosurgical treatment in keloids and hypertrophic scars and to determine factors influencing the therapeutic result. Ninety-three white patients, aged 10 to 79 years (median age, 26 years) with keloids (n = 55; median duration, 36 months; median size, 4 cm2) and with hypertrophic scars (n = 38; median duration, 12 months; median size, 2 cm2) were treated using the contact method. One freeze-thaw cycle of 30 seconds per lesion and session was employed, and, if needed, treatment was repeated every 20 to 30 days. RESULTS Excellent responses (ER) were recorded in 30 subjects (32.3%), good responses (GR) in 27 (29.0%), poor responses (PR) in 27 (29.0%), while nine subjects (9.7%) did not respond at all. Hypertrophic scars responded better (n = 38; GR to ER, 76.3%) than keloids (n = 55; GR to ER, 50.9%; P < .005; odds ratio, 6.92). No progressions or recurrences occurred. Histologically, neovascularization, loss of the anarchic arrangement of collagen bundles, increased fibroblasts in a stroma running parallel to the skin surface, and mononuclear cells mostly arranged at the perivascular area were found in clinically responding lesions. Improved responses were detected in subjects treated with three or more sessions (n = 57; GR to ER, 78.9%) compared with subjects treated once or twice (n = 36; GR to ER, 33.3%; P < .001; odds ratio, 13.68). The cryosurgical treatment was generally well tolerated, with local pain during freezing and/or shortly after treatment (n = 32, 34.4%) and hypopigmentation or hyperpigmentation (n = 11, 11.8%) being the most frequent side effects. CONCLUSIONS Cryosurgery was found effective and safe in keloids and, especially, in hypertrophic scars, in an open, uncontrolled study. Satisfactory results could be obtained after at least three cryosurgical sessions of 30 seconds each, applied once monthly using the contact method of treatment.

[1]  C. Kischer,et al.  Hypertrophic scars and keloids: a review and new concept concerning their origin. , 1982, Scanning electron microscopy.

[2]  R. Dawber,et al.  The historical and scientific basis of cryosurgery , 1982, Clinical and experimental dermatology.

[3]  R. Rudolph,et al.  Wide spread scars, hypertrophic scars, and keloids. , 1987, Clinics in plastic surgery.

[4]  D. D. Datubo-Brown Keloids: a review of the literature. , 1990, British journal of plastic surgery.

[5]  I. Muir,et al.  On the nature of keloid and hypertrophic scars. , 1990, British journal of plastic surgery.

[6]  R. Elton The course of events following cryosurgery. , 1977, The Journal of dermatologic surgery and oncology.

[7]  C. Zouboulis,et al.  [Cryosurgical treatment of hypertrophic scars and keloids]. , 1990, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[8]  E. Peacock,et al.  Biologic basis for the treatment of keloids and hypertrophic scars. , 1970 .

[9]  B. Mende Keloidbehandlung mittels Kryotherapie , 1987 .

[10]  R. Dawber,et al.  The response of keloid scars to cryosurgery. , 1982, Plastic and reconstructive surgery.

[11]  R. Ceilley,et al.  The combined use of cryosurgery and intralesional injections of suspensions of fluorinated adrenocorticosteroids for reducing keloids and hypertrophic scars. , 1979, The Journal of dermatologic surgery and oncology.

[12]  L. Brown,et al.  Keloids: scar revision. , 1986, The Journal of dermatologic surgery and oncology.

[13]  B. Hirshowitz,et al.  [Treatment of keloid scars by combined cryosurgery and intralesional corticosteroids]. , 1982, Harefuah.